BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19825798)

  • 1. A novel method for mining highly imbalanced high-throughput screening data in PubChem.
    Li Q; Wang Y; Bryant SH
    Bioinformatics; 2009 Dec; 25(24):3310-6. PubMed ID: 19825798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and validating predictive decision tree models from mining chemical structural fingerprints and high-throughput screening data in PubChem.
    Han L; Wang Y; Bryant SH
    BMC Bioinformatics; 2008 Sep; 9():401. PubMed ID: 18817552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PubChem BioAssay: A Decade's Development toward Open High-Throughput Screening Data Sharing.
    Wang Y; Cheng T; Bryant SH
    SLAS Discov; 2017 Jul; 22(6):655-666. PubMed ID: 28346087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the PubChem BioAssay resource.
    Wang Y; Bolton E; Dracheva S; Karapetyan K; Shoemaker BA; Suzek TO; Wang J; Xiao J; Zhang J; Bryant SH
    Nucleic Acids Res; 2010 Jan; 38(Database issue):D255-66. PubMed ID: 19933261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR modeling of imbalanced high-throughput screening data in PubChem.
    Zakharov AV; Peach ML; Sitzmann M; Nicklaus MC
    J Chem Inf Model; 2014 Mar; 54(3):705-12. PubMed ID: 24524735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PubChem 2019 update: improved access to chemical data.
    Kim S; Chen J; Cheng T; Gindulyte A; He J; He S; Li Q; Shoemaker BA; Thiessen PA; Yu B; Zaslavsky L; Zhang J; Bolton EE
    Nucleic Acids Res; 2019 Jan; 47(D1):D1102-D1109. PubMed ID: 30371825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data mining PubChem using a support vector machine with the Signature molecular descriptor: classification of factor XIa inhibitors.
    Weis DC; Visco DP; Faulon JL
    J Mol Graph Model; 2008 Nov; 27(4):466-75. PubMed ID: 18829357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PubChem BioAssay: 2014 update.
    Wang Y; Suzek T; Zhang J; Wang J; He S; Cheng T; Shoemaker BA; Gindulyte A; Bryant SH
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1075-82. PubMed ID: 24198245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PubChem's BioAssay Database.
    Wang Y; Xiao J; Suzek TO; Zhang J; Wang J; Zhou Z; Han L; Karapetyan K; Dracheva S; Shoemaker BA; Bolton E; Gindulyte A; Bryant SH
    Nucleic Acids Res; 2012 Jan; 40(Database issue):D400-12. PubMed ID: 22140110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PubChem: a public information system for analyzing bioactivities of small molecules.
    Wang Y; Xiao J; Suzek TO; Zhang J; Wang J; Bryant SH
    Nucleic Acids Res; 2009 Jul; 37(Web Server issue):W623-33. PubMed ID: 19498078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Screening Assay Profiling for Large Chemical Databases.
    Russo DP; Zhu H
    Methods Mol Biol; 2022; 2474():125-132. PubMed ID: 35294761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient algorithm coupled with synthetic minority over-sampling technique to classify imbalanced PubChem BioAssay data.
    Hao M; Wang Y; Bryant SH
    Anal Chim Acta; 2014 Jan; 806():117-27. PubMed ID: 24331047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SVMs modeling for highly imbalanced classification.
    Tang Y; Zhang YQ; Chawla NV; Krasser S
    IEEE Trans Syst Man Cybern B Cybern; 2009 Feb; 39(1):281-8. PubMed ID: 19068445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outlier mining in high throughput screening experiments.
    Engels MF; Wouters L; Verbeeck R; Vanhoof G
    J Biomol Screen; 2002 Aug; 7(4):341-51. PubMed ID: 12230888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
    Jenkins JL; Kao RY; Shapiro R
    Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of training data size and noise level on support vector machines virtual screening of genotoxic compounds from large compound libraries.
    Kumar P; Ma X; Liu X; Jia J; Bucong H; Xue Y; Li ZR; Yang SY; Wei YQ; Chen YZ
    J Comput Aided Mol Des; 2011 May; 25(5):455-67. PubMed ID: 21556903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BioAssay ontology annotations facilitate cross-analysis of diverse high-throughput screening data sets.
    Schürer SC; Vempati U; Smith R; Southern M; Lemmon V
    J Biomol Screen; 2011 Apr; 16(4):415-26. PubMed ID: 21471461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Text-mining based PubChem Bioassay neighboring analysis.
    Han L; Suzek TO; Wang Y; Bryant SH
    BMC Bioinformatics; 2010 Nov; 11():549. PubMed ID: 21059237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data mining a small molecule drug screening representative subset from NIH PubChem.
    Xie XQ; Chen JZ
    J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.